The Effect of Nitrogen Narcosis on Motor Performance in Divers Who Have Sustained an Inner Ear Decompression Illness
NCT07446348 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2026-03-03
Summary
Nitrogen starts to have narcotic properties depths below 30m and can cause symptoms such as euphoria, impaired judgement and impaired neuromuscular coordination. This is an important safety and performance consideration for divers working at depth. 'Dry dive' experiences (also known as 'pot dives') are frequently run by DDRC Healthcare for dive clubs or students who wish to experience nitrogen narcosis and the effects of pressure in a more controlled environment than underwater. The purpose of this study is to investigate the effect of this narcotic effect on oculomotor, vestibular and motor performance by asking participants to perform tasks whilst in the chamber at depth. There will be two groups of participants - those who have had no previous decompression illness or issues with their balance/ inner ear, and divers who have previously sustained an inner ear decompression sickness (IEDCS). It is theorised that divers who have previously sustained an IEDCS injury will struggle more with tasks involving balance and co-ordination under the effect of narcosis. This is because around 60% of divers with IEDCS will have some long-lasting damage to their inner ear and nitrogen narcosis impairs areas of the brain that are being used to compensate for the injury. Therefore, it is possible that inner ear symptoms such as dizziness or disorientation may recur temporarily whilst at depth. Understanding if these divers are at risk will help guide safety advice for returning to diving in the water after an IEDCS injury. If participants decide to take part, they will be asked to complete a medical screening form to ensure that they are safe to undertake a dive in the chamber. They will also be sent some information by DDRC Healthcare including a disclaimer/ consent form which will outline any potential risks or considerations regarding the dive. When participants attend DDRC Healthcare for the planned 'dry' dive they will be shown around the chamber room, and the procedure will be explained. They may ask questions at any point if they have any queries or concerns. The whole session including the dive will take up to 2 hours in total. Prior to entering the chamber, participants will have electrodes attached to areas on their face, head and neck. These will track hand and eye movement and postural stability. Once comfortable, participants will enter the chamber, inside they will be accompanied by a researcher/dive doctor and a chamber attendant. Before the chamber is compressed participants will be asked to perform a series of tasks that the researcher will assist with. The chamber will then be compressed to the equivalent of 40m for a maximum time of 10 minutes, at 40m the series of tasks will be repeated. The chamber will then be slowly decompressed to 6m and then to 3m giving a total time of 36 minutes for the whole dive. For the last 18 minutes participants will breathe oxygen from a mask. Once at surface the series of tasks will be repeat for a third time. Tasks: 1) Recording of eye movements: a. Looking forward with eyes closed b. Following a moving target on a screen c. Looking forward whilst head is moved from left to right by researcher 2) 9-hole peg test (placing pegs into a board and then removing them again) 3) Finger to nose test (pointing to and from a target on a screen and nose) 4) Trial making test (paper and pencil test identifying a sequenced pattern) 5) Postural sway (standing with feet together with eyes open and then closed).
Conditions
- Nitrogen Narcosis
- Inner Ear Decompression Illness
Interventions
- DRUG
-
Nitrogen-oxygen breathing mixture
Hyperbaric chamber dive exposing participants to hyperbaric nitrogen inducing a transitory nitrogen narcosis
Sponsors & Collaborators
-
University of Plymouth
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-09-01
- Primary Completion
- 2028-09-01
- Completion
- 2029-09-01
More Related Trials
-
Role of Instructions in Nitrous Oxide Effects and Choice - 10
NCT00000258 ·Status: COMPLETED ·Phase: NA
-
Neurological Recovery Following NOS-SACD
NCT05714917 ·Status: RECRUITING
-
Nitrous Oxide and EMOtional Cognition
NCT06557642 ·Status: RECRUITING ·Phase: NA
-
Effect of Nitrous Oxide on EEG
NCT04884893 ·Status: COMPLETED ·Phase: PHASE1
-
Nitrous Oxyde Misuse Among Teenagers Consulting in an Addictology Center Dedicated to Young Drug Users in Montpellier
NCT04301024 ·Status: COMPLETED
-
Effect of Nitrous Oxide on Aggression.
NCT06118567 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Levocetirizine and Hydroxyzine on Cognitive and Psychomotor Functioning During Simulated Diving
NCT01496911 ·Status: COMPLETED ·Phase: PHASE4
-
Temporal Dynamics and Pharmacokinetics of Intranasally Administered Oxytocin
NCT03011970 ·Status: COMPLETED ·Phase: PHASE1
-
Examining Expectancy Challenges to Prevent Nonmedical Prescription Stimulant Use
NCT03648684 ·Status: COMPLETED ·Phase: NA
-
Ketamine for Low Mood States in the ER
NCT01209845 ·Status: COMPLETED ·Phase: PHASE1
-
Systemic Ketamine for the Improvement of Post-Operative Analgesia at the Alcohol-Dependent Patient
NCT00329394 ·Status: SUSPENDED ·Phase: PHASE3
-
Acute Dose-dependent Effects of DMT in Healthy Subjects
NCT05384678 ·Status: COMPLETED ·Phase: PHASE1
-
Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls
NCT06789705 ·Status: RECRUITING ·Phase: NA
-
Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy Controls
NCT04648137 ·Status: COMPLETED ·Phase: NA
-
Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA)
NCT01136278 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls
NCT06676774 ·Status: RECRUITING ·Phase: PHASE2
-
Oxytocin's Effect on Socioemotional Aging
NCT01823146 ·Status: COMPLETED ·Phase: NA
-
Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects (DMT BDR-Study)
NCT05695495 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Transdermal Scopolamine on Occupational Performance
NCT00374478 ·Status: COMPLETED ·Phase: PHASE2
-
Behavior Brain Responses
NCT03964350 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Low Dose Ketamine Intra Nasal Traumatology
NCT03233035 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)
NCT01386177 ·Status: COMPLETED ·Phase: PHASE1
-
Oxytocin and Social Behavior Over the Lifespan
NCT00914953 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition
NCT02404688 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Influence of Δ9-tetrahydrocannabinol (THC) on Oxycodone Induced Ventilatory Depression in Healthy Volunteers
NCT05235503 ·Status: UNKNOWN ·Phase: PHASE4